These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10472461)

  • 41. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
    Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
    Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.
    Bujía J; Holly A; Antolí-Candela F; Tapia MG; Kastenbauer E
    Laryngoscope; 1996 Jul; 106(7):865-8. PubMed ID: 8667984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
    Liu D; Ma X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Advances in research on apoptosis in the pathogenesis of acquired middle ear cholesteatoma].
    Song SP; Li WW; Ma XL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jun; 33(6):572-576. PubMed ID: 31163540
    [No Abstract]   [Full Text] [Related]  

  • 48. [Angiogenic factors in external auditory canal cholesteatoma-fibroblast cell culture].
    Naim R; Sadick H; Bayerl C; Bran G; Hörmann K
    HNO; 2005 Nov; 53(11):952-6. PubMed ID: 15870993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
    Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
    Xu Y; Wu Z; Tao Z; Hua Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype.
    Parisier SC; Agresti CJ; Schwartz GK; Han JC; Albino AP
    Am J Otol; 1993 Mar; 14(2):126-30. PubMed ID: 8503484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.
    Bujia J; Kim C; Ostos-Aumente P; Lopez-Villarejo J; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1997; 254(1):6-8. PubMed ID: 9115708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Malignant neoplasm and cholesteatoma with granuloma of the middle ear in the 13-year-old boy].
    Gierek T; Majzel K; Kołodziejczyk M; Kajor M
    Otolaryngol Pol; 1993; 47(6):545-9. PubMed ID: 8164963
    [No Abstract]   [Full Text] [Related]  

  • 55. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
    Liu Y; Cui Y; Yu L; Zhang P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Otogenic brain abscess and middle ear cancer].
    Enders P
    HNO; 1988 Jan; 36(1):45-6. PubMed ID: 3350702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
    Holly A; Sittinger M; Bujía J
    Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.